HSV-1 and HSV-2 Antibodies Positive: Interpretation and Management
A positive HSV-1 and HSV-2 antibody test indicates you have been exposed to both herpes simplex viruses at some point in your life, establishing lifelong latent infection that can reactivate, but this does not require treatment unless you develop symptomatic outbreaks. 1
What This Result Means
Your positive antibody test confirms:
Past or current infection with both HSV-1 and HSV-2 - These are chronic, lifelong infections that persist in nerve ganglia (cervical ganglia for HSV-1, sacral ganglia for HSV-2) 1
Most infections are asymptomatic - 80-90% of genital herpes cases progress subclinically, meaning you may never have recognized symptoms despite being infected 1
You can transmit the virus - Viral shedding occurs intermittently even without visible lesions, allowing transmission during asymptomatic periods 2
Important Diagnostic Caveats
Be aware that HSV-2 antibody tests have significant limitations:
- Low-positive index values (1.1-3.5 on HerpeSelect assays) have poor specificity - only 39.8% accuracy 3
- False-positive rates are substantial, with only 57.4% overall specificity for HSV-2 serology 3
- If your HSV-2 index value is <3.0, confirmatory testing with Western blot should be considered to avoid misdiagnosis 3, 4
- HSV-1 serology has low sensitivity (70.2%), potentially missing true infections 3
Management Recommendations
If You Are Currently Asymptomatic
No antiviral treatment is indicated 1, 2. Management focuses on:
- Counseling about transmission risk - Inform current and future sexual partners about your HSV status
- Recognize potential symptoms - Learn to identify prodromal symptoms (tingling, burning) and typical lesions (vesicles progressing to ulcers)
- Practice safer sex - Use condoms consistently, though they do not eliminate transmission risk entirely
- Avoid sexual contact during outbreaks - Abstain when any lesions are present 5, 2
If You Develop Symptomatic Outbreaks
For first clinical episode with lesions:
- Acyclovir 400 mg orally three times daily for 7-10 days, OR
- Valacyclovir 1 g orally twice daily for 7-10 days, OR
- Famciclovir 250 mg orally three times daily for 7-10 days 2
For recurrent episodes (≥6 per year):
Consider daily suppressive therapy:
- Acyclovir 400 mg orally twice daily, OR
- Valacyclovir 500 mg to 1 g orally once daily, OR
- Famciclovir 250 mg orally twice daily 2
Suppressive therapy reduces recurrence frequency by at least 75% but does not eliminate viral shedding or transmission risk 5
For episodic treatment of recurrences:
- Acyclovir 800 mg orally twice daily for 5 days, OR
- Valacyclovir 500 mg orally twice daily for 5 days, OR
- Famciclovir 125 mg orally twice daily for 5 days 2
Special Populations Requiring Attention
If you are pregnant or planning pregnancy:
- Inform your obstetrician about HSV-2 status
- Risk of neonatal herpes exists, particularly with primary infection near delivery 1
- Suppressive therapy in late pregnancy may be recommended
If you are immunocompromised or HIV-positive:
- Higher doses may be needed (acyclovir 400 mg orally 3-5 times daily)
- Lesions may be more severe, prolonged, and atypical
- Monitor for acyclovir resistance if lesions persist despite treatment 2
Key Clinical Pearls
- HSV-2 causes genital disease almost exclusively, while HSV-1 causes both oral and genital infections due to oro-genital practices 1
- Recurrences are more frequent with HSV-2 genital infection than HSV-1 genital infection 2
- Antibodies do not protect against reactivation - they indicate past exposure but do not prevent recurrent outbreaks 1
- Viral culture or PCR during active lesions is more accurate than serology for diagnosing acute outbreaks, with PCR having >90% sensitivity and specificity 3, 6
Partner Management
Sexual partners should be: